A Marfan syndrome gene expression phenotype in cultured skin fibroblasts

Zizhen Yao1, Jochen C Jaeger, Walter L Ruzzo

  • 1Department of Pathology, University of Washington, Seattle, Washington 98195, USA. yzizhen@cs.washington.edu

BMC Genomics
|September 14, 2007
PubMed
Abstract

Insights

Researchers identified gene expression differences in Marfan syndrome (MFS) patients using DNA macroarrays. These findings highlight potential molecular pathways contributing to this genetic connective tissue disorder.

Area of Science:

  • Genetics
  • Molecular Biology
  • Connective Tissue Disorders

Background:

  • Marfan syndrome (MFS) is an inherited connective tissue disorder.
  • Caused by mutations in the fibrillin-1 gene.
  • MFS is a significant cause of aortic aneurysmal disease, comprising over 5% of thoracic aortic aneurysms.

Purpose of the Study:

  • To identify genes with altered expression levels in MFS.
  • To understand molecular mechanisms contributing to the MFS phenotype.

Main Methods:

  • Utilized spotted membrane DNA macroarrays for gene expression analysis.
  • Analyzed 4132 genes in skin fibroblast cultures.
  • Validated 10 differentially expressed genes using quantitative RT-PCR (qRT-PCR).

Main Results:

  • Identified a subset of genes with significant expression differences between MFS patients and controls.
  • Differential gene expression was strongly associated with MFS status (p < 3 x 10-6).
  • Observed significant inter-individual variation in gene expression ranges in both control and MFS subjects.

Conclusions:

  • Differential gene expression in fibroblasts is linked to Marfan syndrome.
  • The study identified potential molecular markers for MFS.
  • Significant variability in gene expression exists among individuals, even within control groups.